Categories AlphaGraphs, Consumer, Earnings

Philip Morris sees revenue shrink in Q4

Philip Morris International (NYSE: PM) reported fourth-quarter 2020 financial results before the regular market hours on Thursday. The tobacco company reported fourth-quarter revenue of $7.44 billion, down 3.5% year-over-year, but above the Wall Street projection. Net income of $1.26 per share was also higher than what analysts had anticipated.

PM shares were trading flat immediately following the announcement. The stock declined 4% in the trailing 12 months.

Philip Morris International Q4 2020 earnings

Looking forward to listening to management / analyst comments on the results? Stay tuned here for Philip Morris Q4 earnings call transcript

CEO André Calantzopoulos said in a statement, “For the full year, we are expecting a significant recovery, with mid-single-digit organic net revenue growth—driven by the growing contribution of IQOS—and further efforts on cost efficiencies driving an acceleration in forecasted adjusted diluted EPS growth to a range of 9% to 11% on the same basis.”

Prior performance

  • Philip Morris reports Q3 2020 earnings results
  • Philip Morris reports Q2 2020 earnings results
  • philip morris international Q4 2019 earnings

Most Popular

CCL Earnings: Carnival Corp. Q4 2024 revenue rises 10%

Carnival Corporation & plc. (NYSE: CCL) Friday reported strong revenue growth for the fourth quarter of 2024. The cruise line operator reported a profit for Q4, compared to a loss

Key metrics from Nike’s (NKE) Q2 2025 earnings results

NIKE, Inc. (NYSE: NKE) reported total revenues of $12.4 billion for the second quarter of 2025, down 8% on a reported basis and down 9% on a currency-neutral basis. Net

FDX Earnings: FedEx Q2 2025 adjusted profit increases; revenue dips

Cargo giant FedEx Corporation (NYSE: FDX), which completed an organizational restructuring recently, announced financial results for the second quarter of 2025. Second-quarter earnings, excluding one-off items, were $4.05 per share,

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top